Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FLJE9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,611
Award facts
- Contract value 100% obligated
- $15,610.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $15,610.56 delivery order to AmerisourceBergen Drug Corp for supply of Wegovy 1.7 mg/0.75 mL pens on September 26, 2025, with completion expected by September 29, 2025. This firm fixed price contract is unclassified with no set-aside designation, meaning it was competitively awarded. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical prime vendor vehicle operating through December 2026. This underlying IDC enables the company to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The company maintains an established track record fulfilling DLA delivery orders across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This order for Wegovy, a GLP-1 receptor agonist medication used in diabetes and weight management treatment, reflects the company's continued role in supplying brand-name pharmaceuticals to federal healthcare programs through the DLA's supply chain.
Quick answers
Who was awarded contract SPE2DB25FLJE9?
SPE2DB25FLJE9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FLJE9 worth?
The government has obligated $15,611 on SPE2DB25FLJE9.
Is contract SPE2DB25FLJE9 an order under another contract?
Yes. SPE2DB25FLJE9 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB25FLJE9 competed?
The extent of competition for SPE2DB25FLJE9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award